Mecasermin News
Mecasermin currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Mecasermin with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: For the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary IGFD). Severe primary IGFD is defined by: height...
- Evidence level: L5
- Predicted indications (20):
- monosomy X (99.6%)
- Wolman disease with hypolipoproteinemia and acanthocytosis (99.1%)
- growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (99.1%)
- esophageal varices without bleeding (99.0%)
- esophageal varices with bleeding (99.0%)
- autosomal ichthyosis syndrome with fatal disease course (98.7%)
- Gaucher disease (98.5%)
- varicose disease (98.3%)
- congenital pulmonary lymphangiectasia (98.2%)
- cholesteryl ester storage disease (98.2%)
- benign neoplasm of adrenal gland (98.1%)
- 16q24.1 microdeletion syndrome (97.9%)
- primary interstitial lung disease specific to childhood (97.8%)
- isolated pulmonary capillaritis (97.7%)
- familial apolipoprotein C-II deficiency (97.4%)
- Wolman disease (97.2%)
- Steel syndrome (97.2%)
- reticular dysgenesis (97.1%)
- lysosomal acid lipase deficiency (97.0%)
- Hurler syndrome (97.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.